U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07047209) titled 'Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)' on June 18.
Brief Summary: This clinical trial is being conducted to learn about safety and tolerability of digoxin in ALS individuals. Additionally, this trial aims to better understand if digoxin has an effect on slowing neurodegeneration in ALS.
Study Start Date: May 27
Study Type: INTERVENTIONAL
Condition:
ALS (Amyotrophic Lateral Sclerosis)
Intervention:
DRUG: Digoxin
Digoxin tablets will be administered orally in a once daily dosage. Each tablet is scored and is of 125 mcg strength. Participants will take 1 tablet, two tablets or half a tablet...